Kynam Capital Management, LP 13D and 13G filings for Concert Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 09:25 am Unchanged |
2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE |
Kynam Capital Management, LP | 4,420,349 9.200% |
0 (Unchanged) |
Filing |
| 2023-02-10 3:51 pm Purchase |
2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE |
Kynam Capital Management, LP | 4,420,349 9.200% |
4,420,349 (New Position) |
Filing |